Apotheken | Hôpital | Interactions | LiMA | Médecin | Médicaments | Services | T. de l'Autorisation
N06BA04 - MethylphenidateATC-DDD Version 2016. Source: WHO
N - Nervous System
N06 - Psychoanaleptics

This group comprises antidepressants, psychostimulants, nootropics anti-dementia drugs and combinations with psycholeptics.
Antiobesity preparations are classified in A08 - Antiobesity preparations, excl. diet products.

N06B - Psychostimulants, Agents Used for Adhd and Nootropics

Nootropics are classified in N06BX.
Clonidine and guanfacine also used in ADHD are classified in C02AC.

N06BA - Centrally Acting Sympathomimetics

Amfetamine is classified in this group, see comment under A08AA - Centrally acting antiobesity products.

Since atomoxetine is approved for use both in children, adolescents and in adults, the DDD is based on the treatment of a 70 kg person. The majority of the users will, however, probably be under 18 years of age.

N06BA04 - Methylphenidate
30 mgO 
2019 ©ywesee GmbH
Einstellungen | Aide | FAQ | Identification | Contact | Home